Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2023

Sarwate M, Khaitan N, Alpert L, Tavberidze N, Zhang W, Panarelli N, et al. Gastric Glandular Siderosis but not Lamina Propria Siderosis is Associated With High Serum Ferritin Levels. Am J Surg Pathol. 2023;47(9):1052-1058.

Andriano TM, Tannenbaum R, Xu H, Magro CM. Linear IgA bullous dermatosis in the setting of angioimmunoblastic T-cell lymphoma. J Cutan Pathol. 2023;50(1):43-46.

Xie Q, Schenck EJ, Yang HS, Chen Y, Peng Y, Wang F. Faithful AI in Medicine: A Systematic Review with Large Language Models and Beyond. medRxiv. 2023.

Saoud C, Wakely PE, Pantanowitz L, Siddiqui MT, Ali SZ. Chondroblastoma: Cytomorphologic Analysis of 10 Cases with Review of the Literature. Acta Cytol. 2023;67(4):413-424.

Oh W-, Yang Y-, Xie J, Ma H, Kim J-, Park K-, et al. WNT-modulating gene silencers as a gene therapy for osteoporosis, bone fracture, and critical-sized bone defects. Mol Ther. 2023;31(2):435-453.

Geng C, Zhang M-, Manyam GC, Vykoukal JV, Fahrmann JF, Peng S, et al. SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor-Induced Growth Suppression. Clin Cancer Res. 2023;29(21):4464-4478.

Hwang JK, Magro CM, Lipner SR. Nail Unit Arteriovenous Hemangioma Presenting as Longitudinal Erythronychia. Skin Appendage Disord. 2023;9(4):300-305.

Galbraith K, Vasudevaraja V, Serrano J, Shen G, Tran I, Abdallat N, et al. Clinical utility of whole-genome DNA methylation profiling as a primary molecular diagnostic assay for central nervous system tumors-A prospective study and guidelines for clinical testing. Neurooncol Adv. 2023;5(1):vdad076.

Bandini C, Mereu E, Paradzik T, Labrador M, Maccagno M, Cumerlato M, et al. Lysin (K)-specific demethylase 1 inhibition enhances proteasome inhibitor response and overcomes drug resistance in multiple myeloma. Exp Hematol Oncol. 2023;12(1):71.

Yallowitz AR, Shim J-, Xu R, Greenblatt MB. An angiogenic approach to osteoanabolic therapy targeting the SHN3-SLIT3 pathway. Bone. 2023;172:116761.